Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes

Bone Marrow Transplant. 2014 Aug;49(8):1124-6. doi: 10.1038/bmt.2014.108. Epub 2014 May 19.

Authors

P K Bhamidipati¹, J F DiPersio², K Stokerl-Goldstein², A Rashidi², F Gao³, G L Uy², P Westervelt², R Vij², M A Schroeder², C N Abboud², J W Keller², T A Fehniger², R Romee²

Affiliations

¹ Division of Hospital Medicine, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
² Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
³ Department of Biostatistics, Washington University School of Medicine, Saint Louis, MO, USA.

PMID: 24842528
DOI: 10.1038/bmt.2014.108

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Allografts
Disease-Free Survival
Female
Follow-Up Studies
Granulocyte Colony-Stimulating Factor / administration & dosage*
Hematologic Neoplasms* / mortality
Hematologic Neoplasms* / therapy
Hematopoietic Stem Cell Mobilization*
Humans
Lymphocyte Depletion*
Male
Middle Aged
Peripheral Blood Stem Cell Transplantation*
Survival Rate
Time Factors
Transplantation Conditioning*

Substances

Granulocyte Colony-Stimulating Factor

Grants and funding

P30 CA091842/CA/NCI NIH HHS/United States